Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 18,050 | 9,504 | 6,498 | 1,989 | 1,644 |
| Gross Profit | 18,050 | 9,504 | 6,498 | 1,252 | 1,644 |
| Operating Expenses | 28,821 | 26,714 | 27,393 | 31,569 | 22,314 |
| Operating Income | -10,769 | -17,211 | -20,894 | -29,579 | -20,671 |
| Interest Expense | 15,408 | 16,646 | 3,136 | 17,557 | 1,624 |
| Other Income | 3,062 | 8,394 | 29,410 | 5,346 | 4,919 |
| Pre-tax Income | -23,115 | -25,463 | 5,380 | -41,790 | -17,376 |
| Income Tax | -59 | -193 | -262 | 7 | 106 |
| Net Income Continuous | -23,056 | -25,270 | 5,642 | -41,796 | -17,482 |
| Net Income | $-23,056 | $-25,270 | $5,643 | $-41,795 | $-17,482 |
| EPS Basic Total Ops | -0.23 | -0.28 | 0.08 | -0.68 | -0.31 |
| EPS Basic Continuous Ops | -0.23 | -0.28 | 0.08 | -0.66 | -0.31 |
| EPS Diluted Total Ops | -0.23 | -0.28 | -0.15 | -0.68 | -0.31 |
| EPS Diluted Continuous Ops | -0.23 | -0.28 | 0.05 | -0.66 | -0.31 |
| EPS Diluted Before Non-Recurring Items | -0.23 | -0.28 | -0.15 | N/A | N/A |
| EBITDA(a) | $-6,051 | $-12,482 | $-16,326 | $-24,398 | $-16,204 |